Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder A Double-Blind Randomized and Placebo-Controlled Clinical Trial

摘要

Objective: Major depressive disorder (MDD) is predicted to be one of the biggest disease burden in the future. The antidepressant activity of gemfibrozil has been recently considered. In this study, we assessed the effectiveness of gemfibrozil as a sertraline adjunct in treating patients with MDD.